Listing 1 - 10 of 13 | << page >> |
Sort by
|
Choose an application
This report reviews developments in the neuroscience of addiction, explores how they might affect the way we view and treat drug problems, and considers the issues that they raise for drug policy in Europe. In language that is easily accessible, the report presents the complex brain processes involved in addition and the ethical implications inherent to current addiction research.--Publisher's description.
Ethics and addiction --- Community organization --- Abus de drogues --- Drug abuse --- Drug habit --- Drug use (UF) --- Drugmisbruik --- Drugs --- Geneesmiddelen --- Geneesmiddelen, alcohol en verdovende middelen--Misbruik --- Medicamenten --- Medicaments --- Medications --- Medicijnen --- Medicine (Drugs) --- Medicines (Drugs) --- Médicaments --- Pharmaceuticals --- Pharmaceutische produkten --- Prescription drugs --- Toxicomanie --- Drug addiction. --- Social aspects --- Law and legislation --- Aspect social --- Droit --- Médicaments
Choose an application
Abus de drogues --- Drug abuse --- Drug habit --- Drug use (UF) --- Drugmisbruik --- Drugs --- Geneesmiddelen --- Geneesmiddelen, alcohol en verdovende middelen--Misbruik --- Medicamenten --- Medicaments --- Medications --- Medicijnen --- Medicine (Drugs) --- Medicines (Drugs) --- Médicaments --- Pharmaceuticals --- Pharmaceutische produkten --- Prescription drugs --- Toxicomanie --- Intravenous drug abuse --- HIV infections --- Hepatitis. --- Toxicomanie par voie veineuse --- Infections à VIH --- Hépatite --- Diagnosis --- Diagnostic --- E-books --- Infections à VIH --- Hépatite
Choose an application
In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.
Pharmaceutical industry --- Drugs --- Pharmaceutical policy. --- Drug policy --- Drugs and state --- Pharmacy --- Pharmacy and state --- State and drugs --- State and pharmacy --- Medical policy --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Economic aspects. --- Cost effectiveness. --- Government policy
Choose an application
In pharmaceutical patent law, the problem of lack of policy direction and inappropriate legal framework is widespread - particularly among jurisdictions with little to no pharmaceutical research or manufacturing. This book aims to inform public policy and influence debate through a comprehensive review of Hong Kong's pharmaceutical patent law. By demonstrating the need for a holistic review of pharmaceutical patent laws and evaluating Hong Kong's system in light of health policy, economic and social factors, Bryan Mercurio recommends changes to the legal framework and constructs a more efficient and effective system for Hong Kong. He thoroughly evaluates the international framework and best practice models to offer a global perspective to each issue before providing local context in the analysis. While the focus of the book is Hong Kong, the analysis on pharmaceutical patent law and policy extends to other jurisdictions facing issues on reforming their national system.
Pharmacy --- Drugs --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Chemistry --- Medicine --- Law and legislation --- Patent laws and legislation --- Pharmaceutical industry --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Law, Patent --- Patents --- Scientific property --- Industrial laws and legislation --- Industrial property --- Trade regulation --- Copyright
Choose an application
Telecommunicatie - Internet - Europees en internationaal recht telecommunicatie - e-commerce / elektronische handel & publiciteit - definitie - vormen van publiciteit op het internet - wetgeving in het algemeen - bijzondere wetgeving - bescherming van minderjarige(n) (minderjarigheid) & contract / overeenkomst - aanbod - wanneer is het contract afgesloten? (tijdstip contractsluiting) - bijzondere beschouwingen i.v.m. consumentencontract(en) - bijzondere beschouwingen i.v.m. sites betreffende verkoop bij opbod & contentieux - verhaal en sancties - het internationaal privaatrecht (IPR / I.P.R.) - het internationaal strafrecht van toepassing op het internet 1. La publicité.- 2. Le contrat.- 3. le contentieux.
Economic law --- Computer. Automation --- Commercial law. Economic law (general) --- Belgium --- Electronic commerce --- Commerce électronique --- Law and legislation --- Droit --- Internet --- Internet advertising --- 339.5 --- 621.39 --- 34 --- 34:681.3 --- Buitenlandse handel. Internationale handel. Ruilvoet --- Telecommunication. Telecontrol --- Rechtswetenschappen. --- Informaticarecht --- 34:681.3 Informaticarecht --- 34 Rechtswetenschappen. --- 621.39 Telecommunication. Telecontrol --- 339.5 Buitenlandse handel. Internationale handel. Ruilvoet --- Commerce électronique --- Rechtswetenschappen --- 34 Rechtswetenschappen --- 34 Law. Jurisprudence --- Law. Jurisprudence --- Electronic commerce - Law and legislation - Belgium --- Internet - Law and legislation - Belgium --- Internet advertising - Law and legislation - Belgium --- Commerce electronique --- Vente aux encheres --- Droit international penal --- Belgique --- Droit commercial europeen --- Publicite --- Contrat en ligne --- Vente a distance --- Vente de medicaments --- Exequatur
Choose an application
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices.
Drugs --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Prices --- Law and legislation --- Health economics. --- Globalization. --- Economic policy. --- Development economics. --- Health Economics. --- Emerging Markets/Globalization. --- Pharmacoeconomics and Health Outcomes. --- Economic Policy. --- Development Economics. --- Economics, Medical --- Health --- Health economics --- Hygiene --- Medical care --- Medicine --- Economics --- Economic development --- Economic nationalism --- Economic planning --- National planning --- State planning --- Planning --- National security --- Social policy --- Global cities --- Globalisation --- Internationalization --- International relations --- Anti-globalization movement --- Economic aspects --- Markets. --- Pharmacy management. --- Pharmacy administration --- Drugstores --- Health services administration --- Public markets --- Commerce --- Fairs --- Market towns --- Administration --- Management
Choose an application
Antifungal Metabolites of Rhizobacteria for Sustainable Agriculture focuses on plant health in agro-ecosystems of various economically important cash and food crops with a concern to promote sustainable agriculture. They have emerged as a key organic tool for enhancing yields. In a natural environment the interactions between plants and phytopathogenic fungi are complex and survival requires a development of resistance to plant diseases. Diversity of Plant Growth Promoting Rhizobacteria (PGPR) diversity depends on the nature of root exudates and soil conditions that affect their interaction with host plants. Novel strategies, such as, applying bioactive natural products against the pathogenic fungus are required to control disease sustainably. Various classes of secondary metabolites including lipopeptides, macrolides, alkaloids, terpenoids and phenolics from microorganisms and plants strongly suppress fungal growth and can also be effective in controlling plant diseases both in vitro and in vivo. The modes of actions of some potential antifungal secondary metabolites against pathogenic fungus are also discussed. Eco-friendly fungal species and their metabolites are excellent agents used for regulating various fungal and bacterial phytopathogens and may have tremendous potential for other applications, and play a key role in enhancing plant tolerance to stress. Antifungal Metabolites of Rhizobacteria for Sustainable Agriculture also covers bovine-based formulations used for sustainable production and nutritional security through horticultural crops, thereby addressing the problems associated with malnutrition and under-nutrition encountered by small and marginal farmers, as well as by families facing resource constraints. These techniques can also improve breathable air, drinkable water, and consumable foods. This book addresses the need to mitigate the health problems of people via organic crop production and to improve the socio-economic status of farmers (especially in developing countries), and to revitalize agricultural sustainability.
Antifungal agents. --- Fungal metabolites. --- Rhizobacteria. --- Rhizosphere bacteria --- Bacteria --- Soil microbiology --- Fungi --- Microbial metabolites --- Plant metabolites --- Anti-fungal agents --- Antimycotics --- Fungal inhibitory agents --- Inhibitory agents, Fungal --- Therapeutic fungicides --- Anti-infective agents --- Fungicides --- Physiology --- Fungi. --- Mycology. --- Microbiology. --- Biotechnology. --- Agriculture. --- Biology --- Molecular biology. --- Biological Techniques. --- Molecular Biology. --- Technique. --- Fungal kingdom --- Fungus kingdom --- Funguses --- Mycobiota --- Mycota --- Cryptogams --- Mycology --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Farming --- Husbandry --- Industrial arts --- Life sciences --- Food supply --- Land use, Rural --- Chemical engineering --- Genetic engineering --- Microbial biology --- Microorganisms --- Fungal biology --- Fungology --- Fungus biology --- Botany --- Microbiology --- Medicaments antifúngics --- Agricultura sostenible
Choose an application
I. Quelques pas en arrière - II. L'argument économique - III. La chasse aux brevets - IV. Les nouvelles règles du jeu - V. La Corée du Sud, la Thaïlande et le Brésil - VI. Et il y eut l'OMC, et l'accord sur les ADPIC - VII. Médicaments et nouveau régime mondial du brevet : bad trips? - IX. De Pretoria à Doha - X. Doha, le protocole et la grippe aviaire - XI. Le bilatéralisme: la déclaration de Doha, l'état de droit et "The rule of law" - XII. Décembre 2007 : état des lieux et des pratiques : la forteresse ébranlée? - Conclusion - Post-scriptum : trois ans plus tard - Bibliographie
Droit international de la santé --- Droit international de la santé publique --- International public health laws --- International sanitary regulations --- Public health laws [International ] --- Régime sanitaire international --- Réglementation sanitaire internationale --- Santé publique (Droit international) --- Santé publique [Droit international de la ] --- Santé publique--Droit international --- Volksgezondheid--Recht en wetgeving [Internationale ] --- World health--Law and legislation --- Drugs --- Patents (International law) --- Intellectual property --- Right to health. --- Patent infringement --- Poverty --- Médicaments --- Brevets d'invention --- Droit à la santé --- Pauvreté --- Patents. --- Moral and ethical aspects. --- Droit international --- Right to health --- Drug accessibility --- Propriété intellectuelle --- Patents --- Moral and ethical aspects --- Aspect moral --- Contrefaçon --- Accessibilité --- Médicaments --- Propriété intellectuelle --- Droit à la santé --- Pauvreté --- Contrefaçon --- Accessibilité --- EPUB-ALPHA-B EPUB-LIV-FT LIVDROIT STRADA-B --- Law and legislation --- Right to health care --- Developing countries --- Farmaceutische producten : Farmaceutische specialiteiten --- Produits pharmaceutiques : Spécialités pharmaceutiques --- E-books --- Propriété intellectuelle (droit international) --- Santé publique --- Pays en voie de développement
Choose an application
Eating the flesh of an Egyptian mummy prevents the plague. Distilled poppies reduce melancholy. A Turkish drink called coffee increases alertness. Tobacco cures cancer. Such beliefs circulated in the seventeenth and eighteenth centuries, an era when the term "drug" encompassed everything from herbs and spices—like nutmeg, cinnamon, and chamomile—to such deadly poisons as lead, mercury, and arsenic. In The Age of Intoxication, Benjamin Breen offers a window into a time when drugs were not yet separated into categories—illicit and licit, recreational and medicinal, modern and traditional—and there was no barrier between the drug dealer and the pharmacist.Focusing on the Portuguese colonies in Brazil and Angola and on the imperial capital of Lisbon, Breen examines the process by which novel drugs were located, commodified, and consumed. He then turns his attention to the British Empire, arguing that it owed much of its success in this period to its usurpation of the Portuguese drug networks. From the sickly sweet tobacco that helped finance the Atlantic slave trade to the cannabis that an East Indies merchant sold to the natural philosopher Robert Hooke in one of the earliest European coffeehouses, Breen shows how drugs have been entangled with science and empire from the very beginning.Featuring numerous illuminating anecdotes and a cast of characters that includes merchants, slaves, shamans, prophets, inquisitors, and alchemists, The Age of Intoxication rethinks a history of drugs and the early drug trade that has too often been framed as opposites—between medicinal and recreational, legal and illegal, good and evil. Breen argues that, in order to guide drug policy toward a fairer and more informed course, we first need to understand who and what set the global drug trade in motion.
Drug control --- Drugs --- International trade --- Pharmacy --- Drug traffic --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Drug dealing --- Drug production, Illicit --- Drug smuggling --- Drug trade, Illicit --- Drug trafficking --- Illicit drug production --- Illicit drug trade --- Narcotic trade --- Narcotic traffic --- Narcotic trafficking --- Smuggling of drugs --- Smuggling of narcotics --- Traffic, Drug --- Trafficking in drugs --- Trafficking in narcotics --- Drug abuse and crime --- Narco-terrorism --- Drug enforcement --- Drug law enforcement --- Drug policy --- Drug traffic control --- Narcotics, Control of --- War on drugs --- Vice control --- History --- Social aspects&delete& --- Prices and sale --- Government policy --- E-books --- History. --- Social aspects --- Foreign trade. International trade --- Toxicology --- anno 1500-1799 --- Drogues --- Trafic --- Aspect social --- Histoire.
Choose an application
Equitable Access to High-Cost Pharmaceuticals seeks to aid the development and implementation of equitable public health policies by pharmaco-economics professionals, health economists, and policymakers. With detailed country-by country analysis of policy and regulation, the Work compares and contrasts national healthcare systems to support researchers and practitioners identify optimal healthcare policy solutions. The Work incorporates chapters on global regulatory changes, health technology assessment guidelines, and competitive effectiveness research recommendations from international bodies such as the OECD or the EU. Novel policies such as horizon scanning, managed-entry agreement and post-launch monitoring are considered in detail. The Work also thoroughly reviews novel pharmaceuticals with particular research interest, including cancer drugs, orphan medicines, Hep C, and personalized medicines. Evaluates impact and efficacy of current access policies and pricing regulation of high-cost drugs Incorporates existing guidelines and recommendations by international organizations Compares and contrasts how different countries fund and police high-cost drug access Explores novel and emergent policies, including managed entry agreement, analysis of real world data and differential pricing Reviews novel pharmaceuticals of current research interest
Drugs --- Prices. --- Prices --- Law and legislation. --- Farmaceutische producten : Farmaceutische specialiteiten --- Produits pharmaceutiques : Spécialités pharmaceutiques --- medicinal product --- pricing of medicines --- pharmaceutical legislation --- research --- pētniecība --- badania --- истраживање --- έρευνα --- riċerka --- investigación --- cercetare --- kërkim --- ricerca --- výskum --- výzkum --- tyrimai --- истражување --- raziskave --- istraživanje --- investigação --- taighde --- kutatás --- uurimine --- tutkimus --- forskning --- изследване --- Forschung --- recherche --- pesquisa --- ricerca sperimentale --- reachtaíocht chógaisíochta --- farmacevtska zakonodaja --- farmaceutická legislatíva --- legislación farmacéutica --- farmaceutická legislativa --- legislação farmacêutica --- фармацевтично законодателство --- lääkelainsäädäntö --- tiesību akti farmācijas jomā --- farmaceutische wetgeving --- législation pharmaceutique --- lovgivning om apotekervæsen --- prawo farmaceutyczne --- legislație farmaceutică --- legjislacion farmaceutik --- propisi o lijekovima --- läkemedelslagstiftning --- leġiżlazzjoni farmaċewtika --- farmacinę veiklą reguliuojantys teisės aktai --- фармацеутско законодавство --- ravimiseadusandlus --- νομοθεσία φαρμάκων --- legislazione farmaceutica --- Arzneimittelrecht --- gyógyszerjog --- фармацевтско законодавство --- zákon o léčivech --- Arzneimittelgesetz --- contrôle des médicaments --- controlul medicamentelor --- έλεγχος φαρμάκων --- gyógyszerészeti jogszabályok --- φαρμακευτικές διατάξεις --- reglamentación farmacéutica --- läkemedelsbestämmelser --- noteikumi farmācijas jomā --- Arzneimittelkontrolle --- control of medicines --- ravimieeskirjad --- farmacinės veiklos taisyklės --- ljekarničko zakonodavstvo --- normativa farmaceutica --- zāļu kontrole --- ravimite kontroll --- regulamentação farmacêutica --- kontrola liekov --- farmaceutické predpisy --- kontroll i medikamenteve --- akte normative për farmaceutikën --- farmacinės veiklos įstatymai --- regolamentazione farmaceutica --- pharmaceutical regulations --- lääkeasetukset --- controle van geneesmiddelen --- voorschriften inzake geneesmiddelen --- lääkkeiden valvonta --- controllo dei farmaci --- reglementări farmaceutice --- vaistų kontrolė --- réglementation pharmaceutique --- farmacopea nazionale --- farmaceutski propisi --- farmaceutické předpisy --- određivanje cijena lijekova --- oceňovanie liekov --- stanovování cen léčivých přípravků --- fixação de preços de medicamentos --- prisfastsættelse af lægemidler --- ipprezzar tal-mediċini --- Preisfestsetzung für Medikamente --- lääkkeiden hinnoittelu- ja korvausjärjestelmä --- farmaatsiatoodete hinnakujundus --- fijación de precios de medicamentos --- läkemedelsprissättning --- fissazione dei prezzi dei medicinali --- cógais a phraghsáil --- fixation des prix des médicaments --- stabilirea prețurilor medicamentelor --- oblikovanje cen zdravil --- τιμολόγηση φαρμάκων --- vaistų kainų nustatymas --- ustalanie cen produktów leczniczych --- prijsstelling van geneesmiddelen --- zāļu cenu noteikšana --- ценообразуване при лекарствата --- gyógyszerár-támogatás --- pharmaceutical pricing and reimbursement --- vaistų kainodara ir kompensavimas --- stabilirea prețurilor și rambursarea medicamentelor --- pricing and reimbursement of medicinal products --- prisfastsættelse og godtgørelse af lægemidler --- fissazione dei prezzi dei farmaci e rimborsi --- política FPR --- läkemedelssubventioner --- politicile de stabilire a prețurilor la produsele farmaceutice --- Preisfestsetzung und Kostenerstattung für Arzneimittel --- árképzés és visszatérítés --- cenovna politika v farmaciji --- politica de rambursare și de stabilire a prețurilor pentru produsele farmaceutice --- τιμολόγηση φαρμάκων και επιστροφή των δαπανών για φάρμακα --- zāļu cenu politika --- pharmaceutical reimbursement and pricing policy --- P&R policy --- zāļu kompensēšanas un cenu noteikšanas politika --- farmaseuttisten tuotteiden hinnoittelu ja korvattavuus --- medikamentu cenu politika --- fixação de preços e reembolso de produtos farmacêuticos --- prisfastsættelsespolitik for lægemidler --- medikamentu kompensēšana un cenu noteikšana --- politique de fixation des prix des produits pharmaceutiques --- fijación de precios y reembolso de medicamentos --- politika stanovování cen a úhrad léčivých přípravků --- farmaseuttisten tuotteiden hinnoittelupolitiikka --- läkemedelspriser --- Preisfestsetzung und Kostenerstattung für Medikamente --- stanovování cen a úhrady léčivých přípravků --- oblikovanje cen zdravil in povračil zanje --- cenová politika v oblasti liekov --- gyógyszerártámogatás --- πολιτική για την τιμολόγηση των φαρμακευτικών προϊόντων --- politika tal-ipprezzar u tar-rimborż tal-prodotti farmaċewtiċi --- zāļu cenu noteikšanas politika --- politika oceňovania a úhrady liekov --- politica di fissazione dei prezzi e di rimborso dei farmaci --- oceňovanie a úhrada liekov --- ценообразуване и възстановяване на разходите за фармацевтични продукти --- πολιτική τιμολόγησης και επιστροφής δαπανών για φαρμακευτικά προϊόντα --- određivanje cijena i povrat troškova za medicinske proizvode --- πολιτική για την τιμολόγηση των φαρμάκων --- politique de fixation des prix et de remboursement des médicaments --- gyógyszerárképzés --- ustalanie cen i refundacja produktów leczniczych --- политика на ценообразуване при фармацевтичните продукти --- vaistų kainodaros politika --- određivanje cijena farmaceutskih proizvoda --- politika stanovování cen a úhrad léčiv --- politika tal-ipprezzar tal-prodotti farmaċewtiċi --- politika povrata troškova i određivanja cijena u farmaciji --- política de fixação de preços e de reembolso de produtos farmacêuticos --- prisfastsættelse og godtgørelse af lægemidler --- politica di fissazione dei prezzi e di rimborso dei medicinali --- ceny leków i ich refundacja --- politik vedrørende godtgørelse og prisfastsættelse af lægemidler --- Preisgestaltungspolitik für Arzneimittel --- gyógyszerárazási politika --- lääkkeiden hinnoittelupolitiikka --- prijs- en vergoedingenbeleid voor geneesmiddelen --- pharmaceutical pricing policy --- medikamentu cenu noteikšana --- zāļu cenu noteikšana un kompensēšana --- política de fijación de precios de los productos farmacéuticos --- ipprezzar u rimborż tal-prodotti farmaċewtiċi --- politika oceňovania liekov --- cobertura farmacéutica y política de precios --- gyógyszeripari marketing --- prijsbeleid inzake geneesmiddelen --- politika određivanja cijena farmaceutskih proizvoda --- polityka dotycząca ustalania cen leków i refundacji --- fixation des prix et remboursement des produits pharmaceutiques --- oceňovanie a úhrada liekov --- hinnoittelu- ja korvauspolitiikka --- oblikovanje cen in povračila za zdravila --- politica di fissazione dei prezzi dei farmaci --- medikamentu kompensēšanas un cenu noteikšanas politika --- Preisgestaltungs- und Kostenerstattungspolitik für Arzneimittel --- τιμολόγηση φαρμακευτικών προϊόντων και επιστροφή δαπανών --- cenová politika léčiv --- medikamentu cenu noteikšanas politika --- ipprezzar u rimborż tal-prodotti mediċinali --- određivanje cijena farmaceutskih proizvoda i povrat troškova --- politika određivanja cijena u farmaciji i povrata troškova --- fixação de preços e de reembolso de medicamentos --- stabilirea prețurilor și rambursarea produselor farmaceutice --- política de fixação de preços de produtos farmacêuticos --- polityka dotycząca ustalania cen leków --- prijsstelling en vergoeding van geneesmiddelen --- copago farmacéutico y fijación de precios --- prodott mediċinali --- ravim --- φάρμακο --- íoc leighis --- lääke --- medicamento --- médicament --- лек --- medicament --- léčivý přípravek --- produkt leczniczy --- medicinski proizvod --- liek --- medicinale --- geneesmiddel --- Arzneimittel --- zdravilo --- medikament --- vaistinis preparatas --- лекарствен продукт --- gyógyászati készítmény --- lægemiddel --- zāles --- kapky --- orvosság --- lijek --- medicamento per la medicina animale --- medicamento per la medicina umana --- zásyp --- medication --- mast --- medicamente --- medicin --- tabletka --- vaistas --- lek --- medikaments --- medikamentas --- lék --- Arznei --- tinktura --- prodotti mediċinali --- mjekim --- lääkintä --- медикамент --- mediċinament --- prášky --- prášek --- remédio --- liečivý prípravok --- φάρμακα --- лекарство --- gyógyszer --- läkemedel --- lääkitys --- îngrijire medicală --- lääkevalmiste --- prodotto medicinale --- dražé --- medicijn --- Arzneispezialität --- tableta --- čípek --- Medikament --- Läkemedelsprodukter
Listing 1 - 10 of 13 | << page >> |
Sort by
|